Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6015183 | Epilepsy Research | 2016 | 7 Pages |
Abstract
This study demonstrated a long-term benefit of rufinamide as adjunctive therapy for Japanese patients with LGS. Exacerbation of seizures and decreased appetite/weight loss should be monitored carefully.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Yoko Ohtsuka, Harumi Yoshinaga, Yukiyoshi Shirasaka, Rumiko Takayama, Hiroki Takano, Kuniaki Iyoda,